The Venture Codex Logo

The Venture Codex

Novalis Biotech

Ottergemsesteenweg – Zuid 808, Ghent, Oost-Vlaanderen, 9000, Belgium

Overview

Incubator for early-stage biotechnology and life sciences companies.

Founded

2018

Deals · 12mo

2

Links

WebsiteLinkedIn

Stage focus

Seed
Series A

Geographic focus

Belgium
France
Germany
Switzerland
...

Sector focus

Biotechnology
Life Science
Venture Capital

Investment portfolio

11rounds
NAMEDATESIZE
Alithea Genomics
Mar 2026Participated
$9 MSeed
Altavo
Jan 2026Led
$4 MSeries A
Alithea Genomics
Mar 2024Led
$3 MSeed
Altavo
Feb 2024Participated
$5 MSeries A
Enzyre
Nov 2022Participated
$12 MSeries A
Carroucell
Sep 2022Led
$1 MSeries A
Alithea Genomics
May 2022Led
$1 MSeed
Trince
Dec 2021Participated
$5 MOther Equity
RheaVita
Jun 2021Led
$3 MSeries A
GRAPHEAL
Feb 2021Led
$2 MSeed
Enzyre
Jul 2020Led
$2 MOther Equity
Alithea Genomics
Mar 2026Participated
$9 MSeed
Altavo
Jan 2026Led
$4 MSeries A
Alithea Genomics
Mar 2024Led
$3 MSeed
Altavo
Feb 2024Participated
$5 MSeries A
Enzyre
Nov 2022Participated
$12 MSeries A
Carroucell
Sep 2022Led
$1 MSeries A
Alithea Genomics
May 2022Led
$1 MSeed
Trince
Dec 2021Participated
$5 MOther Equity
RheaVita
Jun 2021Led
$3 MSeries A
GRAPHEAL
Feb 2021Led
$2 MSeed
Enzyre
Jul 2020Led
$2 MOther Equity
11
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Novalis Biotech: 11 funding rounds are recorded in the selected participation categories.All available history.
Novalis Biotech: 11 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed31
Series A32
Other Equity11

Monthly Deal Activity

Novalis Biotech: 11 deals are recorded across 76 months.All available history.
Novalis Biotech: 11 deals are recorded across 76 months. All available history
MonthDeals
Jul '201
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '211
Mar '210
Apr '210
May '210
Jun '211
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '211
Jan '220
Feb '220
Mar '220
Apr '220
May '221
Jun '220
Jul '220
Aug '220
Sep '221
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '241
Mar '241
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '261
Feb '260
Mar '261
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Novalis Biotech: Health & Life Sciences is the largest displayed sector by deal count (11 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Novalis Biotech: Health & Life Sciences is the largest displayed sector by deal count (11 deals). All available history
SectorDeals
Health & Life Sciences11
Manufacturing2
Networks, Cloud & Communication1
Hardware & Robotics1
Space & Frontier Tech1

Deal Size Distribution

Novalis Biotech: 11 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Novalis Biotech: 11 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M8
$5M-$10M2
$10M-$25M1
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Novalis Biotech: Europe has the largest recorded deal count among the displayed regions (11 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Novalis Biotech: Europe has the largest recorded deal count among the displayed regions (11 deals). All available history
RegionDeals
Europe11
Novalis Biotech: 18 co-investors are shown, with bm|t sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Novalis Biotech: 18 co-investors are shown, with bm|t sharing 2 recorded deals. All available history
Co-investorShared deals
bm|t2
High-Tech Grunderfonds2
Technologiegründerfonds Sachsen2
TUDAG TU Dresden2
Bpifrance1
Crédit Agricole1
Demcon Investment1
Genku Ventures1
i&i Biotech Fund1
OCCIDENT1
Oost NL1
Ostwerk1
PMV1
Qbic II1
Saxonia Systems Holding1
Takeda Ventures1
TechU Ventures1
Zürcher Kantonalbank1

Investment Strategy

Novalis Biotech: Led accounts for 64% and participating for 36% of round participation.All available history.
Novalis Biotech: Led accounts for 64% and participating for 36% of round participation. All available history
CategoryDeals (count)Share (%)
Led764%
Participating436%
Novalis Biotech: Single-lead accounts for 71% and co-led for 29% of lead dynamics.All available history.
Novalis Biotech: Single-lead accounts for 71% and co-led for 29% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead571%
Co-led229%

Team

Jan Berghe

Managing Director & Co-Founder

Jan Van den Berghe
Kjell Mortier

Fund Manager

Wim van Criekinge

Co-Founder & Managing Director